butabarbital will lessen the level or effect of amlodipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

butabarbital will lower the extent or outcome of pioglitazone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unfamiliar.

butabarbital will decrease the extent or result of ritonavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.

butabarbital will decrease the level or effect of pitolisant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Intently. Pitolisant exposure is reduced by fifty% if coadministered with potent CYP3A4 inducers.

Negative effects that typically do not demand health care awareness (report to your doctor or health treatment Skilled should they proceed or are bothersome):

butabarbital will lessen the level or influence of lorlatinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism.

fentanyl intranasal and butabarbital the two increase sedation. Avoid or Use Alternate Drug. Limit use to people for whom alternate procedure alternatives are inadequate

butabarbital will decrease the extent or result of docetaxel by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unidentified.

If you pass up a dose of the medication, consider it as quickly as possible. Nevertheless, if it is almost time for the future dose, skip the skipped dose and return to your standard dosing program. Don't double doses.

Working with this medication with any of the subsequent medicines may well induce an elevated possibility of sure side effects, but using both prescription drugs will be the finest treatment method for yourself. If both of those medicines are prescribed with each other, your medical professional may well change the dose or website how often you use a person or both of the medicines.

butabarbital will decrease the extent or result of nilotinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.

butabarbital will reduce the extent or result of mavacamten by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.

butabarbital will minimize the level or outcome of dapsone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unfamiliar.

butabarbital will decrease the level or impact of diclofenac by influencing hepatic enzyme CYP2C9/10 metabolism. Slight/Significance Unidentified.